The latest closing stock price for SAB Biotherapeutics as of November 20, 2024 is 3.06.
An investor who bought $1,000 worth of SAB Biotherapeutics stock at the IPO in 2021 would have $-581 today, roughly -1 times their original investment - a -25.16% compound annual growth rate over 3 years.
The all-time high SAB Biotherapeutics stock closing price was 11.24 on December 01, 2021.
The SAB Biotherapeutics 52-week high stock price is 6.39, which is 108.8% above the current share price.
The SAB Biotherapeutics 52-week low stock price is 0.62, which is 79.7% below the current share price.
The average SAB Biotherapeutics stock price for the last 52 weeks is 3.43.
An investor who bought $1,000 worth of SAB Biotherapeutics stock at the IPO in 2021 would have $-581 today, roughly -1 times their original investment - a -25.16% compound annual growth rate over 3 years.
The all-time high SAB Biotherapeutics stock closing price was 11.24 on December 01, 2021.
The SAB Biotherapeutics 52-week high stock price is 6.39, which is 108.8% above the current share price.
The SAB Biotherapeutics 52-week low stock price is 0.62, which is 79.7% below the current share price.
The average SAB Biotherapeutics stock price for the last 52 weeks is 3.43.